BBCMS Mortgage Trust Files ABS-EE Report on Commercial Mortgages
BBCMS Mortgage Trust 2026-5C41 files an ABS-EE report detailing commercial mortgage activities, reflecting trends in the asset-backed securities market.
Citigroup unveils new medium-term senior notes pricing
Citigroup Inc. files pricing supplement for medium-term senior notes, reflecting strategic financial moves in the National Commercial Banks sector.
Barclays Bank announces $3.2M buffered autocallable notes
Barclays Bank PLC files for $3.2 million in buffered autocallable notes linked to major equities, reflecting its innovative approach in commercial banking.
Barclays Bank announces $358,000 Buffered Supertrack Notes
Barclays Bank PLC files pricing supplement for $358,000 Buffered Supertrack Notes linked to S&P 500 Futures Excess Return Index.
Citigroup unveils new unsecured debt securities linked to S&P 500
Citigroup Inc. announces a new offering of unsecured debt securities linked to the S&P 500 Futures Excess Return Index, enhancing its funding capabilities.
GS Finance Corp. issues $620,000 in buffered Nasdaq-100 notes
GS Finance Corp. announces $620,000 in buffered Nasdaq-100 linked notes, reflecting its strategy in the competitive security brokers and dealers sector.
Citigroup unveils new unsecured debt securities linked to S&P 500
Citigroup Inc. files a pricing supplement for new unsecured debt securities linked to the S&P 500 Futures Index, impacting the national commercial banking sector.
GS Finance Corp. files for $3.3 million in callable notes
GS Finance Corp. files for $3.3 million in callable index-linked notes due 2032, guaranteed by The Goldman Sachs Group, Inc.
Morgan Stanley Finance LLC Files Pricing Supplement for New Securities
Morgan Stanley Finance LLC announces new Buffered PLUS securities set to mature in 2031, reflecting strategic growth in structured investments.
JPMorgan Chase Financial Co. files pricing supplement for notes
JPMorgan Chase Financial Co. LLC files a pricing supplement for new note offerings linked to market indices, indicating ongoing investment strategies.
Citigroup Files Pricing Supplement for Senior Notes Offering
Citigroup Inc. has filed a pricing supplement for new medium-term senior notes, reflecting strategic moves in the national commercial banking sector.
Morgan Stanley Finance LLC Files Pricing Supplement for New Securities
Morgan Stanley Finance LLC announces a new structured investment offering based on the S&P 500 Index, highlighting trends in innovative financial products.
Citigroup files pricing supplement for new senior notes
Citigroup Inc. has filed a pricing supplement for its Medium-Term Senior Notes linked to major stock indices, signaling a strategic funding move.
Citigroup files pricing supplement for Medium-Term Notes
Citigroup Inc. has filed a preliminary pricing supplement for its Medium-Term Senior Notes, Series G, indicating a strategic capital raise.
LINEI0926 SPV raises $4 million in private offering
LINEI0926 SPV a Series of JHL Investment SPV LLC has completed a $4 million private offering, signaling growth in the pooled investment fund sector.
Wells Fargo Trust Updates Asset-Backed Securities Filing
Wells Fargo Commercial Mortgage Trust 2025-C65 amends its asset-backed securities filing, updating key asset data and related documents.
Faex Technologies Inc. raises $4.5 million in new offering
Faex Technologies Inc. has filed a new offering to raise $4.5 million, with $2.5 million already committed, signaling growth potential in the tech sector.
Apollo Infrastructure amends offering under Rule 506(b)
Apollo Infrastructure Co LLC has amended its offering under Rule 506(b), reflecting changes in its capital strategy and impacting the Electric, Gas & Sanitary Services industry.
JPMorgan Chase Financial Co. files for new investment notes
JPMorgan Chase Financial Co. LLC files a preliminary pricing supplement for structured investment notes linked to the S&P 500 Futures Excess Return Index.
Conic Public Biotech Fund LP Launches New Private Offering
Conic Public Biotech Fund LP files for a new private equity offering under Rule 506(b), aiming for indefinite fundraising in the biotech sector.